147 related articles for article (PubMed ID: 11076094)
1. Cervical epidermal growth factor-receptor (EGF-R) and serum insulin-like growth factor II (IGF-II) levels are potential markers for cervical cancer.
Mathur SP; Mathur RS; Young RC
Am J Reprod Immunol; 2000 Oct; 44(4):222-30. PubMed ID: 11076094
[TBL] [Abstract][Full Text] [Related]
2. Human papilloma virus (HPV)-E6/E7 and epidermal growth factor receptor (EGF-R) protein levels in cervical cancer and cervical intraepithelial neoplasia (CIN).
Mathur SP; Mathur RS; Rust PF; Young RC
Am J Reprod Immunol; 2001 Oct; 46(4):280-7. PubMed ID: 11642677
[TBL] [Abstract][Full Text] [Related]
3. Serum vascular endothelial growth factor C (VEGF-C) as a specific biomarker for advanced cervical cancer: Relationship to insulin-like growth factor II (IGF-II), IGF binding protein 3 (IGF-BP3) and VEGF-A [corrected].
Mathur SP; Mathur RS; Gray EA; Lane D; Underwood PG; Kohler M; Creasman WT
Gynecol Oncol; 2005 Sep; 98(3):467-83. PubMed ID: 15982726
[TBL] [Abstract][Full Text] [Related]
4. Circulating levels of insulin-like growth factor-II and IGF-binding protein 3 in cervical cancer.
Mathur SP; Mathur RS; Underwood PB; Kohler MF; Creasman WT
Gynecol Oncol; 2003 Dec; 91(3):486-93. PubMed ID: 14675666
[TBL] [Abstract][Full Text] [Related]
5. Early non-invasive diagnosis of cervical cancer: beyond Pap smears and human papilloma virus (HPV) testing.
Mathur SP; Mathur RS; Creasman WT; Underwood PB; Kohler M
Cancer Biomark; 2005; 1(2-3):183-91. PubMed ID: 17192039
[TBL] [Abstract][Full Text] [Related]
6. Cervical scrapes levels of insulin-like growth factor-II and insulin-like growth factor binding protein 3 in women with squamous intraepithelial lesions and cervical cancer.
Serrano ML; Sánchez-Gómez M; Bravo MM
Horm Metab Res; 2010 Dec; 42(13):977-81. PubMed ID: 20945273
[TBL] [Abstract][Full Text] [Related]
7. Increased sialylation and reduced fucosylation of exfoliated cervical cells are potential markers of carcinogenesis in the cervix.
Jin Y; Kim SC; Kim HJ; Ju W; Kim YH; Kim HJ
Clin Chem Lab Med; 2016 Nov; 54(11):1811-1819. PubMed ID: 27092648
[TBL] [Abstract][Full Text] [Related]
8. Differentially expressed proteins among normal cervix, cervical intraepithelial neoplasia and cervical squamous cell carcinoma.
Zhao Q; He Y; Wang XL; Zhang YX; Wu YM
Clin Transl Oncol; 2015 Aug; 17(8):620-31. PubMed ID: 25893434
[TBL] [Abstract][Full Text] [Related]
9. Vascular endothelial growth factor (VEGF) up-regulates epidermal growth factor receptor (EGF-R) in cervical cancer in vitro: this action is mediated through HPV-E6 in HPV-positive cancers.
Mathur RS; Mathur SP
Gynecol Oncol; 2005 Apr; 97(1):206-13. PubMed ID: 15790460
[TBL] [Abstract][Full Text] [Related]
10. Insulin-like growth factor II in gynecological cancers: a preliminary study.
Mathur SP; Landen CP; Datta SM; Hoffman MC; Mathur RS; Young RC
Am J Reprod Immunol; 2003 Feb; 49(2):113-9. PubMed ID: 12765350
[TBL] [Abstract][Full Text] [Related]
11. In vitro downregulation of growth factors by insulin-like growth factor binding protein-3 in cervical cancer.
Mathur RS; Mathur SP
Gynecol Oncol; 2003 Nov; 91(2):410-5. PubMed ID: 14599874
[TBL] [Abstract][Full Text] [Related]
12. Expression of phosphorylated histone H2AX (γ-H2AX) in normal and neoplastic squamous epithelia of the uterine cervix: an immunohistochemical study with epidermal growth factor receptor.
Brustmann H; Hinterholzer S; Brunner A
Int J Gynecol Pathol; 2011 Jan; 30(1):76-83. PubMed ID: 21131828
[TBL] [Abstract][Full Text] [Related]
13. Serum levels of insulin-like growth factor-I and -II and insulin-like growth factor binding protein 3 in women with squamous intraepithelial lesions and cervical cancer.
Serrano ML; Romero A; Cendales R; Sánchez-Gómez M; Bravo MM
Biomedica; 2006 Jun; 26(2):258-68. PubMed ID: 16925098
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical evaluation of insulin-like growth factor I receptor status in cervical cancer specimens.
Kuramoto H; Hongo A; Liu YX; Ojima Y; Nakamura K; Seki N; Kodama J; Hiramatsu Y
Acta Med Okayama; 2008 Aug; 62(4):251-9. PubMed ID: 18766208
[TBL] [Abstract][Full Text] [Related]
15. Use of protein-based biomarkers of exfoliated cervical cells for primary screening of cervical cancer.
Jin Y; Kim SC; Kim HJ; Ju W; Kim YH; Kim HJ
Arch Pharm Res; 2018 Apr; 41(4):438-449. PubMed ID: 29492827
[TBL] [Abstract][Full Text] [Related]
16. Cox-2, EGFR, and ERBB-2 expression in cervical intraepithelial neoplasia and cervical cancer using an automated imaging system.
Fukazawa EM; Baiocchi G; Soares FA; Kumagai LY; Faloppa CC; Badiglian-Filho L; Coelho FR; Gonçalves WJ; Costa RL; Góes JC
Int J Gynecol Pathol; 2014 May; 33(3):225-34. PubMed ID: 24681731
[TBL] [Abstract][Full Text] [Related]
17. [Analysis of differentially expressed proteins in normal cervix, cervical intraepithelial neoplasia and cervical squamous carcinoma tissues].
Zhao Q; Wu YM; He Y; Wang XL; Chen S; Qian XH; Zhang YX
Zhonghua Zhong Liu Za Zhi; 2013 Dec; 35(12):914-20. PubMed ID: 24506961
[TBL] [Abstract][Full Text] [Related]
18. Tumor-specific correlation of tumor M2 pyruvate kinase in pre-invasive, invasive and recurrent cervical cancer.
Landt S; Jeschke S; Koeninger A; Thomas A; Heusner T; Korlach S; Ulm K; Schmidt P; Blohmer JU; Lichtenegger W; Sehouli J; Kuemmel S
Anticancer Res; 2010 Feb; 30(2):375-81. PubMed ID: 20332442
[TBL] [Abstract][Full Text] [Related]
19. Serum vascular endothelial growth factor and serum leptin in patients with cervical cancer.
Lebrecht A; Ludwig E; Huber A; Klein M; Schneeberger C; Tempfer C; Koelbl H; Hefler L
Gynecol Oncol; 2002 Apr; 85(1):32-5. PubMed ID: 11925116
[TBL] [Abstract][Full Text] [Related]
20. Serum levels of angiogenin (ANG) in invasive cervical cancer and in cervical intraepithelial neoplasia (CIN).
Bodner-Adler B; Hefler L; Bodner K; Leodolter S; Frischmuth K; Kainz C; Mayerhofer K
Anticancer Res; 2001; 21(1B):809-12. PubMed ID: 11299848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
